Avinger announces issuance of new u.s. patent and receives notices of allowance for five additional u.s. patents

Redwood city, ca / accesswire / september 18, 2024 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced the issuance of a new u.s. patent and the allowance of five additional u.s. patents that are expected to issue over the next four months. these patents expand intellectual property protection for avinger's proprietary image-guided system and devices for both peripheral and coronary applications.
AVGR Ratings Summary
AVGR Quant Ranking